News release

Date: 7th December 2011

Past president of TOPRA and ELC GROUP Advisor speaks at International Regulatory Seminar in Ahmedabad 23 February 2012

ELC GROUP hosts international seminar on EU Regulatory challenges for 2012

Cambridge, UK, December 7th 2011 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today announces that it will be hosting an international training seminar on 23rd February 2012 in Ahmedabad, India. The event will address the regulatory challenges for 2012 and their impact on marketing authorisation.

As well as an overview of the latest changes in European Regulatory Procedures, the day will focus on the implementation of electronic submission of medical production information in the new EU requirements of the Pharmacovigilance legislation.


The full-day course will cover the evolution of the registration systems available for approval of products in the EU, together with major changes in New Medicines Legislation. These changes include regulatory procedures, access to Centralised and Mutual Recognition Procedures and reduction in Regulatory Data protection.
There will also be discussion on regulatory strategy which impacts on commercial, business and licensing arrangements and will be of importance to those responsible for business development.


ELC GROUP’s Advisory Board member, Dr. Paolo Biffignandi MD, PhD, QPPV, FTOPRA, will host the day. Dr. Biffignandi has over 30 years’ experience in Regulatory Affairs and pharmacovigilance. He is a past President and now Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA) and a renowned physician, with PhDs in endocrinology and pharmacology. He is also an Overseas Fellow of the Royal Society of Medicine (UK) and provides a regulatory column for EPM magazine (European Pharmaceutical Manufacturer).
Speaking about seminar, Marco Rubinstein ELC GROUP CEO said: “We are delighted to be hosting this event and sharing Paolo’s expert knowledge with an ever increasing audience. This event will be a fantastic opportunity for attendees to meet experts in the complex field of EU Pharma regulation.”


You can register to attend online here: http://www.elc-group.com/index.php?option=com_content&view=article&id=57&Itemid=48

----ends----


Press contacts

Akhil Jain
ELC Group
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00

Nicky Denovan
EvokedSet PR
nicky [at] evokedset [dot] com
Phone: +44 (0)7747 017654


About ELC Group (www.elc-group.com)
ELC GROUP is a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries as well as REACH services to the Chemical industry. It helps companies that lack the resource (skills and knowledge) to cost-effectively deliver regulatory affairs.

ELC Group provides full-service, multi-lingual consulting and cost-effective solutions to regulatory approvals using experts with in-depth knowledge and experience throughout the world. The team ranges from former FDA investigators to individuals with over 30 years of industry experience with broad capabilities. This includes integrated advanced technologies, regulatory affairs consulting and commercialisation services.



Close This Window